Copyright
©The Author(s) 2016.
World J Gastroenterol. Nov 21, 2016; 22(43): 9586-9594
Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9586
Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9586
Variable | Training group (n = 97) | Validation group (n = 96) | ||
F = 4 | F ≥ 2 | F = 4 | F ≥ 2 | |
AUC | 0.84 | 0.797 | 0.792 | 0.778 |
Sensitivity | 83.10% | 83.30% | 74.70% | 79.40% |
Specificity | 78.60% | 67.30% | 88.20% | 67.70% |
PPV | 39.60% | 76.94% | 57.70% | 76.29% |
NPV | 96.50% | 75.48% | 94.20% | 71.51% |
- Citation: Zeng DW, Dong J, Jiang JJ, Zhu YY, Liu YR. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase. World J Gastroenterol 2016; 22(43): 9586-9594
- URL: https://www.wjgnet.com/1007-9327/full/v22/i43/9586.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i43.9586